T cell responses in acute measles

Viral Immunology

Volumn 15, Issue 3, 2002, Pages 435-450

  Van Els, Cécile A C M ^a   Nanan, Ralph ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANTIGEN DETECTION; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; CELL COMPOSITION; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MEASLES VIRUS; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TECHNOLOGY; VIRUS INFECTION;

ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEASLES; MEASLES VIRUS; T-LYMPHOCYTE SUBSETS; VIRAL PROTEINS;

ALPHAVIRUS; DNA VIRUSES; MEASLES VIRUS;

EID: 0036380630     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282402760312322     Document Type: Review

References (126)

1. Albrecht, P., F.A. Ennis, E.J. Saltzman, et al. 1977. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J. Pediatr. 91:715-718.
2. Alexander-Miller, M.A., M.A. Derby, A. Sarin, et al. 1998. Supraoptimal peptide-major histocompatibility complex causes a decrease in bcl-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes. J. Exp. Med. 188:1391-1399.
3. Altfeld, M.A., B. Livingston, N. Reshamwala, et al. 2001. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J. Virol. 75:1301-1311.
4. Altman, J.D., P.A. Moss, P.J. Goulder, et al. 1996. Phenotype analysis of antigen-specific T lymphocytes. Science 274:94-96.
5. Avota, E., A. Avots, S. Niewiesk, et al. 2001. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat. Med. 7:725-731.
6. + cytotoxic T lymphocyte response to two specific epitopes. Virology 200:281-283.
7. Beauverger, P., R. Buckland, and T.F. Wild. 1993. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. J. Gen. Virol. 74:2357-2363.
8. Beauverger, P., A.I. Cardoso, L. Daviet, et al. 1996. Analysis of the contribution of CTL epitopes in the immunobiology of the morbillivirus infection. Virology 219:133-139.
9. + T-cell response is much less apparent following secondary challenge. J. Virol. 74:3486-3493.
10. Bercovici, N., M.T. Duffour, S. Agrawal, et al. 2000. New methods for assessing T-cell responses. Clin. Diagn. Lab Immunol. 7:859-864.
11. Bhardwaj, N. 1997. Interactions of viruses with dendritic cells: a double-edged sword. J. Exp. Med. 186:795-799.
12. Boon, A.C., G. de Mutsert, Y.M. Graus, et al. 2002. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J. Virol. 76:2567-2572.
13. Brodsky, A.L. 1972. Atypical measles. Severe illness in recipients of killed measles virus vaccine upon exposure to natural infection. JAMA 222:1415-1416.
14. Burnet, F.M. 1968. Measles as an index of immunological function. Lancet 2:610-613.
15. Callan, M.F., and A.J. McMichael. 1999. T cell receptor usage in infectious disease. Springer Semin. Immunopathol. 21:37-54.
16. + T cells in acute infectious mononucleosis. Nat. Med. 2:906-911.
17. Cardoso, A.I., P. Beauverger, D. Gerlier, et al. 1995. Formaldehyde inactivation of measles virus abolishes cd46- dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells. Virology 212:255-258.
18. Cardoso, A.I., D. Gerlier, T.F. Wild, et al. 1996. The ectodomain of measles virus envelope glycoprotein does not gain access to the cytosol and MHC class I presentation pathway following virus-cell fusion. J. Gen. Virol. 77:2695-2699.
19. + T-cell memory in the respiratory tract. Nat. Med. 8:54-60.
20. + responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J. Virol. 73:7108-7116.
21. De Groot, A.S., A. Bosma, N. Chinai, et al. 2001. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 19:4385-4395.
22. Demotz, S., W. Ammerlaan, P. Fournier, et al. 1998. Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185-199 in the endosomal compartment. Clin. Exp. Immunol. 114:228-235.
23. + T cells: cross-priming in infectious diseases. Curr. Opin. Immunol. 13:437-441.
24. El Kasmi, K.C., D. Theisen, N.H. Brons, et al. 1999. A hemagglutinin-derived peptide-vaccine ignored by virus- neutralizing passive antibodies, protects against murine measles encephalitis. Vaccine 17:2436-2445.
25. + CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein. J. Immunol. 167:384-391.
26. Ferris, R.L., C. Buck, S.A. Hammond, et al. 1996. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope protein. J. Immunol. 156:834-840.
27. Finke, D., U.G. Brinckmann, M. ter V, et al. 1995. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:5469-5474.
28. + T cells are essential in overcoming experimental murine measles encephalitis. Immunology 83:184-189.
29. Fournier, P., W. Ammerlaan, D. Ziegler, et al. 1996. Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides. Int. Immunol. 8:1441-1451.
30. Fugier-Vivier, I., C. Servet-Delprat, P. Rivailler, et al. 1997. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:813-823.
31. Fulginiti, V.A., J.J. Eller, A.W. Downie, et al. 1967. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202:1075-1080.
32. + T cells in healthy and immunosuppressed virus carriers. Blood 98:754-761.
33. Gandhi, R.T., and B.D. Walker. 2002. Immunologic control of HIV-1. Annu. Rev. Med. 53:149-172.
34. Gans, H.A., A.M. Arvin, J. Galinus, et al. 1998. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280:527-532.
35. Giraudon, P., R. Buckland, and T.F. Wild. 1992. The immune response to measles virus in mice. T-helper response to the nucleoprotein and mapping of the T-helper epitopes. Virus Res. 22:41-54.
36. Good, R.A., and S.J. Zak. 1956. Disturbances in gamma globulin synthesis as "experiments of nature." Paediatrics 18:109-149.
37. Griffin, D.E., and B.J. Ward. 1993. Differential CD4 T cell activation in measles. J. Infect. Dis. 168:275-281.
38. Griffin, D.E., B.J. Ward, and L.M. Esolen. 1994. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J. Infect. Dis. 170:S24-S31.
39. Griffin, D.E., B.J. Ward, E. Jauregui,. et al. 1990. Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161:449-453.
40. Gromme, M., F.G. Uytdehaag, H. Janssen, et al. 1999. Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. U.S.A. 96:10326-10331.
41. + T cells. J. Exp. Med. 186:801-812.
42. + CTL. J. Immunol. 154:6140-6156.
43. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18:275-308.
44. Herberts, C.A., K.J. Stittelaar, H.E. van der, et al. 2001. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway. J. Gen. Virol. 82:2131-2142.
45. + T-cell memory. Nat. Med. 7:913-919.
46. Hombach, J., H. Pircher, S. Tonegawa, et al. 1995. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J. Exp. Med. 182:1615-1619.
47. Hunt, D.F., R.A. Henderson, J. Shabanowitz, et al. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-1263.
48. Isa, M.B., L. Martinez, M. Giordano, et al. 2001. Measles virus-specific immunoglobulin G isotype immune response in early and late infections. J. Clin. Microbiol. 39:170-174.
49. Jacobson, S., R.P. Sekaly, C.L. Jacobson, et al. 1989. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J. Virol. 63:1756-1762.
50. Jaye, A., A.F. Magnusen, A.D. Sadiq, et al. 1998. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. J. Clin. Invest. 102:1969-1977.
51. Jaye, A., A.F. Magnusen, and H.C. Whittle. 1998. Human leukocyte antigen class I- and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults. J. Infect. Dis. 177:1282-1289.
52. Kaech, S.M., E.J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-262.
53. Kamperschroer, C., and D.G. Quinn. 1999. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocyte choriomeningitis virus infection. Cell Immunol. 193:134-146.
54. Kaplan, L.J., R.S. Daum, M. Smaron, et al. 1992. Severe measles in immunocompromised patients. JAMA 267:1237-1241.
55. Kleijmeer, M.J., J.M. Escola, F.G. Uytdehaag, et al. 2001. Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2:124-137.
56. +-T-cell epitope in Mycobacterium tuberculosis Rv2903c. Infect. Immunol. 70:981-984.
57. Kourilsky, P., and P. Truffa-Bachi. 2001. Cytokine fields and the polarization of the immune response. Trends Immunol. 22:502-509.
58. Koziel, M.J. 1997. The role of immune responses in the pathogenesis of hepatitis C virus infection. J. Viral Hepatol. 4:31-41.
59. Krasinski, K., and W. Borkowsky. 1989. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA 261:2512-2516.
60. Kreth, H.W., M. ter V, and G. Eckert. 1979. Demonstration of HLA restricted killer cells in patients with acute measles. Med. Microbiol. Immunol. (Berl.) 165:203-214.
61. Kwok, W.W., J.A. Gebe, A. Liu, et al. 2001. Rapid epitope identification from complex class-II-restricted T-cell antigens. Trends Immunol. 22:583-588.
62. Lanzavecchia, A. 2002. Lack of fair play in the T cell response. Nat. Immunol. 3:9-10.
63. Lennon-Dumenil, A.M., A.H. Bakker, P. Wolf-Bryant, et al. 2002. A closer look at proteolysis and MHC-class-II-restricted antigen presentation. Curr. Opin. Immunol. 14:15-21.
64. Liebert, U.G., and D. Finke. 1995. Measles virus infections in rodents. Curr. Topics Microbiol. Immunol. 191:149-166.
65. Marie, J.C., J. Kehren, M.C. Trescol-Biemont, et al. 2001. Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity 14:69-79.
66. Markowitz, L.E., F.W. Chandler, E.O. Roldan, et al. 1988. Fatal measles pneumonia without rash in a child with AIDS. J. Infect. Dis. 158:480-483.
67. Marttila, J., A. Hinkkanen, T. Ziegler, et al. 2001. Cell membrane-associated measles virus components inhibit antigen processing. Virology. 279:422-428.
68. Mathias, R.G., W.G. Meekison, T.A. Arcand, et al. 1989. The role of secondary vaccine failures in measles outbreaks. Am. J. Public Health 79:475-478.
69. McMichael, A.J., and S.L. Rowland-Jones. 2001. Cellular immune responses to HIV. Nature 410:980-987.
70. Mitus, A., J.F. Enders, J.M. Craig, et al. 1959. Persistence of measles virus and depression of antibody formation in patients with giant cell pneumonia after measles. N. Engl. J. Med. 261:882-889.
71. Mongkolsapaya, J., A. Jaye, M.F. Callan, et al. 1999. Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J. Virol. 73:67-71.
72. Mosse, C.A., L. Meadows, C.J. Luckey, et al. 1998. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187:37-48.
73. Mossong, J., D.J. Nokes, W.J. Edmunds, et al. 1999. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am. J. Epidemiol. 150:1238-1249.
74. Muller, C.P., W. Ammerlaan, B. Fleckenstein, et al. 1996. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein. Int. Immunol. 8:445-456.
75. Murali-Krishna, K., J.D. Altman, M. Suresh, et al. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
76. Nahmias, A.J., D. Griffith, C. Salsbury, et al. 1967. Thymic aplasia with lymphopenia, plasma cells, and normal immunoglobulins. Relation to measles virus infection. JAMA 201:729-734.
77. + memory T cells in measlesseropositive individuals by in vitro peptide stimulation. Clin. Exp. Immunol. 102:40-45.
78. Nanan, R., A. Rauch, E. Kampgen, et al. 2000. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J. Gen. Virol. 81:1313-1319.
79. Neefjes, J. 1999. CIIV, MIIC and other compartments for MHC class II loading. Eur. J. Immunol. 29:1421-1425.
80. Neumeister, C., R. Nanan, T. Cornu, et al. 2001. Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway. J. Gen. Virol. 82:441-447.
81. + T cells depends on the H-2 molecule. J. Gen. Virol. 79:2583-2591.
82. Niewiesk, S., M. Gotzelmann, and M. ter V. 2000. Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection. Proc. Natl. Acad. Sci. U.S.A. 97:4251-4255.
83. Niewiesk, S., H. Ohnimus, J.J. Schnorr, et al. 1999. Measles virus-induced immunosuppression in cotton rats is associated with cell cycle retardation in uninfected lymphocytes. J. Gen. Virol. 80:2023-2029.
84. Norrby, E., G. Enders-Ruckle, and V. Meulen. 1975. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J. Infect. Dis. 132:262-269.
85. Okada, H., T.A. Sato, A. Katayama, et al. 2001. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Arch. Virol. 146:859-874.
86. Okamura, A., O. Itakura, M., Yoshioka, et al. 2001. Unusual presentation of measles giant cell pneumonia in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. 32:E57-E58.
87. Openshaw, P.J., F.J. Culley, and W. Olszewska. 2001. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine 20:S27-S31.
88. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463-467.
89. Partidos, C.D., P. Vohra, D. Jones, et al. 1997. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles. J. Immunol. Methods 206:143-151.
90. Polack, F.P., P.G. Auwaerter, S.H. Lee, et al. 1999. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat. Med. 5:629-634.
91. Rauh, L.W., and R. Schmidt. 2000. Measles immunization with killed virus vaccine. Serum antibody titers and experience with exposure to measles epidemic. Bull. World Health Organ. 78:226-231.
92. Ravanel, K., C. Castelle, T. Defrance, et al. 1997. Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. J. Exp. Med. 186:269-278.
93. + T cells control measles virus infection of the central nervous system. Immunology 76:185-191.
94. Ressing, M.E., A. Sette, R.M. Brandt, et al. 1995. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J. Immunol. 154:5934-5943.
95. Rima, B.K., J.A., Earle, K. Baczko, et al. 1995. Measles virus strain variations. Curr. Topics Microbiol. Immunol. 191:65-83.
96. Rivailler, P., M.C. Trescol-Biemont, C. Gimenez, et al. 1998. Enhanced MHC class II-restricted presentation of measles virus (MV) hemagglutinin in transgenic mice expressing human MV receptor CD46. Eur. J. Immunol. 28:1301-1314.
97. Robadey, C., W. Ammerlaan, C. Muller, et al. 1997. The processing routes determined by negatively charged residues in DR1-restricted T cell determinants. J. Immunol. 159:3238-3246.
98. Romagnani, S. 2000. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85:9-18.
99. Schadeck, E.B., C.D. Partidos, A.R. Fooks, et al. 1999. CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice. Virus Res. 65:75-86.
100. Schneider-Schaulies, S., K. Bieback, E. Avota, et al. 2002. Regulation of gene expression in lymphocyte and antigen-presenting cells by measles virus: consequences for immunomodulation. J. Mol. Med. 80:73-85.
101. Schneider-Schaulies, S., S. Niewiesk, J. Schneider-Schaulies, et al. 2001. Measles virus induced immunosuppression: targets and effector mechanisms. Curr. Mol. Med. 1:163-181.
102. Schneider-Schaulies, S. and M. ter V. 1999. Pathogenic aspects of measles virus infections. Arch. Virol. Suppl. 15:139-158.
103. Schueler-Furman, O., Y. Altuvia, A. Sette, et al. 2000. Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci. 9:1838-1846.
104. Singh, H., and G.P. Raghava. 2001. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17:1236-1237.
105. Sissons, J.G., S.D. Colby, W.O. Harrison, et al. 1985. Cytotoxic lymphocytes generated in vivo with acute measles virus infection. Clin. Immunol. Immunopathol. 34:60-68.
106. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827-1835.
107. Tortorella, D., B.E. Gewurz, M.H. Furman, et al. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18:861-926.
108. Uytdehaag, F.G., R.S. van Binnendijk, M.J. Kenter, et al. 1994. Cytotoxic T lymphocyte responses against measles virus. Curr. Topics Microbiol. Immunol. 189:151-167.
109. + cytotoxic T cell clones. J. Immunol. 142:2847-2854.
110. van Binnendijk, R.S., C.A. van Baalen, M.C. Poelen, et al. 1992. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I-and class II-restricted cytotoxic T cell recognition. J. Exp. Med. 176:119-128.
111. van Binnendijk, R.S. J.P. Versteeg-van Oosten, M.C. Poelen, et al. 1993. Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes in the measles virus fusion protein. J. Virol. 67:2276-2284.
112. van Els, C.A., C.A. Herberts, H.E. van der, et al. 2000. A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains. Eur. J. Immunol. 30:1172-1181.
113. Varga, S.M., and R.M. Welsh. 1998. Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory. J. Immunol. 161:367-374.
114. Vidalain, P.O., O. Azocar, B. Lamouille, et al. 2000. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74:556-559.
115. Villadangos, J.A. 2001. Presentation of antigens by MHC class II molecules: getting the most out of them. Mol. Immunol. 38:329-346.
116. Ward, C.L., S. Omura, and R.R. Kopito. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121-127.
117. Watts, C., and S. Powis. 1999. Pathways of antigen processing and presentation. Rev. Immunogenet. 1:60-74.
118. + T cells in the prevention of measles virus-induced encephalitis in mice. J. Gen. Virol. 81:2707-2713.
119. Weidinger, G., G. Henning, M. ter V, et al. 2001. Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma interferon leads to breakdown of resistance against measles virus-induced encephalitis. J. Virol. 75:3059-3065.
120. + T cell responses. Curr. Opin. Immunol. 12:448-455.
121. + stability? Nat. Med. 7:892-893.
122. Whitmire, J.K., M.S. Asano, K. Murali-Krishna, et al. 1998. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72:8281-8288.
123. Wiertz, E.J., T.R. Jones, L. Sun, et al. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779.
124. Xu, X.N., G.R. Screaton, and A.J. McMichael. 2001. Virus infections: escape, resistance, and counterattack. Immunity 15:867-870.
125. Yewdell, J.W., and J.R. Bennink, 2001. Cut and trim: generating MHC class I peptide ligands. Curr. Opin. Immunol. 13:13-18.
126. York, I.A., and K.L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369-396.